4-5 September 2020

Open to experienced oncologists.

Learning objectives:

• An increasing number of therapeutics that require biomarkers testing are available for clinical use or are in advanced phase of clinical development
• Different technologies can be used for biomarker testing depending on the nature of the biomarker and the availability of biological samples
• The increasing use of large panels for comprehensive genomic profiling raises issues on data interpretation that require a multidisciplinary approach
• Monitoring the molecular evolution of the disease might allow the identification of resistance mechanisms and the development of more effective therapeutic strategies
• The identification of germline variants requires the activation of genetic counselling programs for patients and their families

Application only for the members of the Oncologists Association of Uzbekistan before August 13, 2020.

You can apply here: https://esmoeducation.formstack.com/forms/application_esmo_virtual_advanced_course_biomarkers_precision_medicine_4_5_september_2020